Top Stories
Image source: Getty Images In the past five years, Barclays (LSE: BARC)…
BioVaxys Technology Corp. is developing its patented DPX™ platform to address the challenges of lipid nanoparticles (LNPs) in mRNA vaccine delivery. Learn how DPX improves stability, immune responses, and manufacturing economics as the mRNA vaccine market projects $48 billion growth by 2030.
Image source: Getty Images The Lloyds (LSE: LLOY) share price is…
Image source: Getty Images I have my eye on two dividend…
Image source: Getty Images It hasn’t been a trouble-free journey for…
Image source: Rolls-Royce plc There is – as Theresa May once…
Investments
Investment in large-scale wind and solar in Australia has reached its highest…
Economy Insights
National News
Image source: Getty Images I’ve always seen Tesco (LSE: TSCO) shares as solid but dull. And I’ve never bought them. Which just shows how wrong I can…
Image source: Getty Images Growth stocks are those that are growing (of course) but specifically those that are doing it faster than the average, whether that’s the…
Image source: Getty Images FTSE 250 gambling-focused technology stock Playtech (LSE: PTEC) was an absolute gem last year. As my fellow Fool Ken Hall pointed out back…
I was very close to buying Nvidia (NASDAQ:NVDA) shares in May. After the company’s latest earnings report however, I’m glad I didn’t. The numbers themselves were impressive.…
Image source: The Motley Fool Warren Buffett’s latest Berkshire Hathaway portfolio update in May made headlines, but one of the most interesting developments has gone largely unnoticed:…
Image source: Getty Images Barclays’ (LSE: BARC) share price is near its 21 May one-year high of £3.31. Any break above that would see it hit levels…